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Abstract
We always strive to minimize the impact of bias in observational studies due to possible

nonrandom treatment assignment. Propensity score and inverse weighting methods both attempt
to achieve this goal. Inverse probability weighting is the method based on Horvitz and
Thompson (1952) while propensity score is based on Rosenbaum and Rubin (1983). Because
they are the most prevalent methods in longitudinal studies, these methods should be evaluated
to find out which is better in reducing bias and producing accurate estimates. However, there are
few studies comparing the two approaches. In a study of theory and simulated data, Ertefaie and
Stephens (2010) demonstrated that, in simple cases, multivariate generalized propensity score
(MGPS) routinely produced estimators with lower Mean-Square Error (MSE) when compared to
inverse probability weighting (IPW). In the same paper, however, they were unable to show the
same result in a longitudinal dataset. In this paper, I will perform similar comparisons in the
treatment effect hazard ratio estimates as well as the efficiency of the estimates, specifically the
variance of the two methods in an observational longitudinal public health study. I will only
compare the direct effect of treatment, or the unconfounded and unmediated effect on expected
response, since this is the only place where Propensity score and Inverse Weighting methods are
comparable, and demonstrate that PS may not be the best method of analysis for reducing bias in
longitudinal time-to-event studies, despite theoretical studies to the contrary. The results show
that the treatment effect hazard ratio estimates with the two approaches are indistinguishable,
although PS is consistently efficient while IPW varies based on whether stabilization occurs and
on covariates.
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Introduction
In a perfect world, the designers of experimental studies and controlled clinical trials

would attempt to randomly assign subjects or patients to a condition or treatment group.
However, in real-life studies, the “assignment” of a person to a treatment group or condition is
usually not entirely random, unless specifically designed. Observational studies are, by design,
not likely to be random in group or condition “assignment”. Prominent statisticians have spent
years inventing and introducing methods to reduce the biases in experimental studies. And in the
recent decade, competing methods have been slowly overtaken in popularity by weighting
methods.
Even though inverse probability weighting (IPW) method was first introduced in the
1950s (Horvitz and Thompson, 1952), it was, for an extended period, widely considered
inefficient relative to likelihood based methods (Clayton et al. 1998), and resulted in estimates
sensitive to the precise form of the model for the probability of response (Little and Rubin,
1987), Robins and colleagues proposed improved IPW estimates that mitigated both problems in
a series of papers in the 1990s, such as Robins et al. (1995), Robins and Rotnizky (1995), and
Scharfstein et al (1999). IPW is a weight equal to the inverse of the probability of response by
treatment group.
Another method of reducing bias is the propensity score (PS). PS, first proposed by
Rosenbaum and Rubin (1983, 84), is defined as the conditional probability of receiving the
treatment given pre-treatment covariates. IPW and PS are thus constructed in similar fashion.
First, a model for treatment group or condition is fitted. The resulting conditional model for the
outcome is then fitted either through weighting for IPW or matching for PS.
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Despite the theoretical similarity of the two bias-reducing methods, there have been very
few direct comparison studies between them. Ertefaie and Stephens (2010) found that PS
outperformed IPW in mean squared error (MSE) in single and multiple interval simulation
studies. However, no preference was found for either method using real data from Mother’s
Stress and Children’s Morbidity Study, a small (N=167) longitudinal study. Tan (2007) also
could not show superior efficiency of an IPW or IPW-like estimator over that of a regression
estimator based on controlling for all pretreatment variables, essentially a PS estimator. Hirano et
al. (2003) found the two estimators to be asymptotically equivalent.
In this paper, we compare PS and IPW in a large (n=5698) longitudinal time to event
dataset from the Medicare Current Beneficiary Survey (MCBS). We will examine the
performance indicators, such as the variance and MSE, of the estimators produced by the two
methods for establishing the magnitude of the direct effect of treatment, without any of the
confounding effects. The main focus is on direct effect of the treatment because it is the only
situation where IPW and PS methods can be directly compared. The hazard ratio estimates of all
other potential covariates for the effect of covariates are interesting to discuss but not directly
comparable, because only IPW adjustment plays a role in estimating the effects of other
covariates.

3

Methods
3.1

Propensity Score (PS)

As previously discussed, propensity score is a method of reducing bias in treatment effect
estimation. At its most basic form, PS is defined for binary treatment as
π(x) = p(Tr = 1|x),
4

where π(x) is the propensity score, Tr is treatment, and x is the covariate, by Rosenbaum and
Rubin (1983) and is the most basic function of covariates that has the balancing property, which
means treatment assignment is independent of covariates given the propensity score. This, of
course, requires all confounding variables to be known as well as the existence of a real choice
between treatment and control for each patient at the time of treatment selection, both critical
criteria for what Rosenbaum and Rubin (1983) called the assumption of a strongly ignorable
treatment assignment.
To produce the least biased propensity score model, it is important to not only include
covariates that are correlated with treatment but also those correlated with outcome, as doing so
would decrease the precision of the treatment effect estimate (Brookhart et al, 2006) Variables
whose removal result in insignificant changes in estimated treatment effect and an increase in
precision are seen as unlikely confounders and can be safely removed from propensity model
(Hill and Kleinbaum, 2000). The average treatment effect can be computed from propensity
score estimates using iterated expectation
µ = E[Y(1) – Y(0)] = Eπ(X){E[Y(1)| π(X)] – E[Y(0)| π(X)]}
where Eπ(X) is the expectation with respect to the distribution of π(X) in the entire population
(Ertefaie and Stephens, 2010)
The propensity scores produced can be used to find a conditional estimate of treatment
effects given propensity score π, over the distribution of π. This can be best accomplished
through matching between treatment and control patients, stratification, or using the PS directly
as a covariate in the regression. Matching protects against misspecification of the propensity
model but can significantly reduce sample size. Many existing user-generated programs and
macros with numerical matching algorithms exist for SAS and other statistical analysis tools.
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Stratification is similar to matching in effectiveness w
without
ithout the risk of losing subjects due to a
lack of strong assumptions on time dependency of the effect of PS on the outcome. A quasiquasi
standard of 5 strata exists for stratification based on the work of Cochran (1968). But Cochran
also suggests that more than
an 5 strata should be used for larger datasets to further reduce
imbalance. However, because stratification aims to produce treatment groups with similar
probability of receiving treatment versus control, the individuals in the strata may be
indistinguishable
ble for further clinical decision making. (Curtis et al, 2007)
For our MCBS dataset, the estimated PS is used directly in the model as a covariate. It is
an easy method to implement since the absolute standardized difference between the probability
of outcome
ome in the treated group and the probability of outcome in the untreated group can be
determined (Austin 2008). But an incorrect assumption about the functional relationship between
PS and outcome,, such as assuming assignment to treatment group to be a pro
prognostic
gnostic factor by
itself after controlling for other covariates, can negate the benefits of PS and lead to biased
results (Rosenbaum and Rubin, 1983). Therefore, both the first step of propensity score model
and the second step of establishing functional rrelationship
elationship between PS and the outcome need to
be correct in order to correct bias.
In a dataset with time-varying
varying covariates, a generalized propensity score method is more
appropriate. If we set Yij, Trij, and Xij, as the response, treatment, and covariates
tes of unit i at time
j,, respectively, then we can find πij as the propensity score. Moodie and Stephens (2010) then
find, for every dose tr,
Yij (tr)

Trij | πij (tr, Xij),

and with it the E[Yij (tr) | πij (tr, Xij)] can be found as the unbiased estimate over the distribution
of covariate Xij.
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Any proposed propensity score model can be adequate as long as balance is achieved,
that is, the distribution of covariates X for different values of treatment Tr for each strata of PS π
is approximately balanced. While any score that achieve balance will provide unbiased estimates
of the treatment effect, the variance depends strictly on the definition of the PS (Ertefaie and
Stephens 2010). In this case, variance is obtained using the standard model-based variance
estimate. The results for the propensity score method were generated by Ling Han, MD, MS of
the Yale Program on Aging/Pepper Center Biostatistics Core.

3.2

Inverse Probability Weighting (IPW)

The basic idea of IPW is conceptually easy to grasp and to program. A simple example is
presented by missingdata.org.uk (2012)
Suppose we saw the following data,
Group
A
B
C
Response 1 1 1 2 2 2 3 3 3

then the average response is 2. However if we observed
Group
A
Response 1 ? ?

B
2 2 2

C
? 3 3

then the average response is 13/6, which is biased. However, the probability of response is 1/3 in
group A, 1 in group B and 2/3 in group C. We can therefore calculate a weighted average, where
each observation is weighted by 1/{Probability of response}:

3
3
1  1  2  2  2  1  3  3 
2
3 3
3
11122
1
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Thus, in this case, inverse probability weighting (IPW) has eliminated the bias by
adjusting for measured data. More
ore generally we will see it may still give biased parameter
estimates, just less of them.
We can then expand the idea for treatment that is confounde
confounded.
d. Unbiased estimates of the
treatment parameter can even be obtained using a weighted analysis, assuming there are no
unmeasured confounders. For a binary treatment (treated/untreated or treated/placebo), much like
beta blocker use we have in our present data, for each subject i the weight wi = 1 + e-ηi is
assigned, where
ηi = logit{p(Tr = tri | X = xi)} = β0 + β1xi
where tri is the observed binary treatment and xi the observed confounder for subject i. This
weight,, essentially an ideological extension of the propensity score discussed earlier, can then be
used in a weighted regression of Y on observed treatment T and components of X in order to find
an average treatment effect.
While the estimated weight is theoretically asymptotically unbiased, in practice wi is
highly variable. This can be amended by stabilization, replacing the numerator of the weight with
the marginal probability of receiving the treatment. The resulting stabilized weight,
weight according to
Robins (1997) is
swi = f (tri) / f (tri | xi)
where (tri, xi) are treatment and confounders as previously described
described,, and f is the probability
density function.. The further expansion of this idea for multilevel and continuous treatment is
discussed by Robins et al (2000), where the stabilized we
weight becomes
swi f (tri) / f (tri | xi),
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provided that the initial logistic model calculating the weight is correctly specified. The Marginal
structural models (MSM), a class of causal models for the estimation of the causal effect of a
time-dependent exposure in the presence of time-dependent covariates that may be
simultaneously confounder and intermediate variables from observational data, are consistently
estimated by IPW estimators (Robins et al, 2000).
The IPW we already introduced, however, only accounts for confounders at baseline. To
adjust for time-varying aspect of potential covariates, stabilized IPW for patient i at visit j are the
product of inverse probability of exposure defined as
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where 0 is a vector of zeroes,   a vector of fixed baseline variables and   a vector of timevarying variables. The denominator adjusts for bias while the numerator stabilizes. Therefore,
unstabilized IPW for the same patients are just
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The magnitude of nonpositivity bias increases with the number of time points and decreases with
the use of appropriately stabilized weights (Cole and Hernán, 2008). In most cases, lack of
stabilization results in larger variance estimates. Therefore, stabilization is generally preferred in
order to achieve greater efficiency for no real cost.
IPW adjusted time-to-event analysis is a derivative of using such weights in controlling
of confounding in analyzing survival data, as described by Robins et al (2000). A Cox regression
model, weighted by estimated stabilized weights, accounts for cofounding by the covariate
vector X because the “pseudo-population” created by weighting on the covariate X are unrelated
to treatment Tr (Cole and Hernán, 2004). The use of the Cox model further removes the need for
9

adjusting our IPW for the inverse probability of censoring. Variance of the hazard ratio estimate,
obtained through a Cox model, is normally estimated through the robust variance estimator of
Lin and Wei (1989) so that variance estimate is valid under null hypothesis and provides
conservative confidence interval range. However, in this case we must utilize the sandwich
estimator, similar to generalized estimating equations proposed by Zeger et al. (1988),
accounting for the variability in estimating the weights. Based on Carpenter and Kenward
(2006), if we write the estimating equation for β as Σni=1 µi(β) = 0, and the estimating equation for
the logistic regression on the probability of observing X1i, parameterized by α, as Σni=1 νi(α) = 0.
Then, let wi(β, α) = (µT, νT)T. And finally, let
"

-

#
.

&
(
%&'
$

0

0

,
&
*
&) +/0,12

Then the sandwich estimator of the variance of treatment effect is the upper 4 x 4 block of
" 3∑-. 5 6'7 , )895 : 6'7 , )89;" .

SAS programming is used in both data transformation and analysis with this method.

4

Data and Analysis
4.1

MCBS

The dataset used in the analysis is a subset of 3752 patients between 2002 and 2006 in the
large Medicare Current Beneficiary Survey (MCBS) that focuses on the effect of beta-blocker
usage in patients with co-existing coronary artery disease and COPD or after myocardial
infarction (MI) patients for combating adverse cardiovascular events. Even though randomized
controlled trials have repeatedly shown beta-blockers to effectively protect the heart after MI
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according to the meta-analysis of Freemantle et al. (1999), this is an excellent opportunity to
study the overall cardio-protective effectiveness of binary beta-blocker use in a strongly
representative subset of the overall elderly population regardless of previous MIs. The subset
includes patients from age 65 to 103, with the mean age being 78.39 years and median age 78,
which is exactly what one would expect of the Medicare utilizing population.
Each individual had a variety of cardiovascular risk factors recorded, including sex, race,
prior myocardial infarction, stent CABG, smoking status, etc. Based on enrollment date, each
patient was observed for an entire year with no repeated measurement of the covariates and only
seen when an adverse cardiac event occurs or at the end of the observational period. 1946 of the
uncensored patients were followed for a further year with new measurements of the covariates
under similar conditions. We use these data to determine treatment effect of beta-blocker use on
cardiac health. Logistic regressions are used to fit the model for weights and propensity score
over each interval over all relevant covariates, including the cardiovascular risk factors
introduced earlier, as well as mobility, hypertension, diabetes, oral corticosteroid use, prior
stroke, congenital heart defect, dementia, end stage renal disease, and a few others.

4.2

PS versus stabilized and unstabilized IPW

The resulting logistic models that include all the possible covariates, collectively shown
as xij, for unit i and time j are
logit{p(tri1 = 1)} = α0 + α1xi1
logit{p(trij = 1)} = β0 + β1tri(t-1) + β2ci(t-1) + β3xi1
for t =1 and t >1, where c is the response variable and tr is treatment.
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We can then model our binary response, adverse cardiac symptoms, using cox regression
with beta-blocker usage, all relevant time-varying covariates, and either PS as a covariate or
weighting by IPW of treatment. The Cox proportional hazard model must then be generalized in
order to fit the time-varying covariates. This is easily handled in theory for Cox regression
models and in practice with modern statistical programming software such as SAS. Ties are
resolved using the standard Breslow method for Cox regression and life model (Breslow, 1974).
We compare the estimates and the variance of treatment effect of beta-blockers using PS,
stabilized IPW, as well as unstabilized IPW. The results of the analysis are presented in Table 1
below.
Table 1: Parameters estimates based on IPW and PS for MCBS adverse cardiac events
study.
Hazard Ratio Estimate

Standard Error

No Covariates
0.975
All Covariates
0.985
No Covariates
0.984
Stabilized
IPW
All Covariates
1.029
PS
1.033
* Sandwich variance estimate used for all IPW method variances
^ Hazard Ratio Estimate compares beta-blocker users vs nonusers
Untabilized
IPW

0.06411
0.08709
0.11878
0.11059
0.07487

95% Hazard Ratio
Confidence Limits
(0.861, 1.105)
(0.830, 1.168)
(0.780, 1.242)
(0.828, 1.278)
(0.892, 1.197)

We can see that the treatment effects are all not significant and very similar to each other.
Because of the consistent overlap between estimated treatment effect confidence interval
regardless of any of the methods listed, it is difficult to say that one is preferable to another in
terms of estimation efficiency. In fact, even the general rule that stabilized IPW has lower
variance was not true in our case. Adjusting for covariates did not make much of a difference in
unstabilized IPW in terms of the hazard ratio estimate for beta-blocker users versus nonusers.
But doing the same in stabilized IPW pushed the hazard ratio estimate in line with PS hazard
12

ratio estimate. Unfortunately, the difference was still rather small and within the range of the
confidence interval.

4.3

Bootstrap

To more accurately access the precision of the hazard ratio estimates of the treatment
effect of beta-blocker use, we can use bootstrapping to find standard error. A bootstrap sample is
an independent random sample of size n taken from dataset x with replacement. The bootstrap

replication of statistic <= = s(x) is <= > = s(? > ) and the bootstrap estimate of standard error is the

observed standard deviation of repeated bootstrap replications. (Efron and Tibshirani, 1993) As

the number of independent samples approaches infinity, <= > is approximately normally distributed
and the bootstrap estimate of standard error approaches the estimate of the actual sample
standard error. Precisely, the bootstrap estimate of standard error is calculated thusly,
@A
B

C∑F. DE

0 > .GH
0 > FE


, where <= > . 

∑F.

0 > F
E


.

For our data, we ran k=100 bootstrap sampling of the original dataset through the same models.
Table 2 illustrates the comparison between model estimates and bootstrap estimates of hazard
ratio for beta-blocker users versus nonusers and standard errors for all methods in Table 1.
Table 2: Comparison between model estimates and bootstrap estimates of hazard ratio for
beta-blocker users versus nonusers and standard errors
Hazard Ratio
Estimate

Standard
Error

0.975 0.06411
0.985 0.08709
0.984 0.11878
Stabilized IPW
1.029 0.11059
PS
1.033 0.07487
* Sandwich variance estimate used for all IPW method variances
Unstabilized
IPW

No Covariates
All Covariates
No Covariates
All Covariates
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Bootstrapped Hazard
Ratio Estimate
0.976
0.989
0.983
1.034
1.037

Bootstrapped
Standard Error
0.06598
0.07608
0.07895
0.10037
0.07877

^ Hazard Ratio Estimates are for beta-blocker users versus nonusers

We can see here that bootstrapped hazard ratio estimates and standard errors are very
close to the estimates the model of the original dataset produced. One noticeable difference was
in the standard error of the unadjusted treatment effect of beta-blocker use, where the standard
error dropped from a high of 0.11878 to be more in line with other standard errors. More
importantly, we can state that the standard error of the treatment effect adjusted for all important
covariates with the stabilized IPW method is higher than that through other methods and
therefore less efficient in this case.

4.4

Truncated IPW

We may further adjust the IPW models with truncation methods as suggested by Cole and
Hernán (2008). They indicate that the choice of the model used to construct weights may impact
the results of the marginal structural model. This choice is based on an informal bias-variance
tradeoff between inclusion of a sufficient number of flexibly modeled confounders in the weight
model and well-behaved weights. Truncation methods allow us to explore this trade-off and can
give us a more refined comparison between the hazard ratio for beta-blocker users versus
nonusers and variance estimates obtained through stabilized and unstabilized IPWs. The simplest
way to explore such a tradeoff is through progressive truncation, developed by Kish (1992). In
this method, weights are truncated by resetting the values of weights greater or less than
percentile p(100-p) to the value of the weights at percentile p(100-p). The comparison of
truncation-adjusted IPW between stabilized and unstabilized weights for our study is presented
below in Table 3.
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Table 3: Comparison of truncated IPW between stabilized and unstabilized weights for
MCBS adverse cardiac events study.
Truncated Percentile Mean (SD) Min Max Hazard Ratio Estimate
0, 100 1.18 (0.68) 0.11 11.46
0.985
1, 99 1.16 (0.54) 0.67 4.04
0.967
5, 95 0.95 (0.35) 0.86 2.38
0.951
Unstabilized
IPW
10, 90 1.07 (0.21) 0.91 1.64
0.956
25, 75 1.01 (0.03) 0.97 1.05
0.949
50, 50 1.02 (0.00) 1.02 1.02
0.948
0, 100 0.42 (0.31) 0.01 4.48
1.029
1, 99 0.41 (0.26) 0.05 1.58
0.999
5, 95 0.40 (0.21) 0.10 0.93
0.983
Stabilized
IPW
10, 90 0.38 (0.16) 0.14 0.64
0.978
25, 75 0.37 (0.11) 0.23 0.51
0.973
50, 50 0.39 (0.00) 0.39 0.39
0.948
* Sandwich variance estimate used for all IPW method variances
^ Hazard Ratio Estimates are for beta-blocker users versus nonusers

SE
0.0871
0.0795
0.0779
0.0743
0.0735
0.0734
0.1106
0.0981
0.0899
0.0830
0.0762
0.0734

Here the first row of each section corresponds to the marginal structure model adjusted
for covariates for unstabilized and stabilized weight, respectively. Similarly, the last row of each
section corresponds to the previously not shown baseline-adjusted model, which has a weight of
1 for every subject, is why the hazard ratio estimates are the same with either method. We can
see that precision of the estimate increases as truncation increases. However, bias also increases
since we are truncating more of the weights. Therefore, in this case and assuming the marginal
structural model estimate is unbiased, it is unlikely for the small gain in precision to outweigh
the increase in bias.

5

Discussion and Summary
Past studies, such as Chamberlain (1987), Hahn (1998), Hirano et al. (2003), and Ertefaie

and Stephens (2010) have collectively demonstrate the theoretical superiority of propensity score
15

method over inverse probability weighting method in MSE, variance, efficiency, and bias
removal, assuming correct model specification in general longitudinal studies. But no simulation
seems to exist for show the same for longitudinal time-to-event data. A real dataset like our study
on the MCBS impact of beta-blocker use on adverse heart event data shows that, in a large
empirical public health dataset with longitudinal time-to-event binary outcome, could not
conclusively determine PS method as having better performance than IPW methods. We were
able to show that PS results in a numeric variance estimate of the treatment effect hazard ratio
estimate that is similar to that using the unstabilized IPW method, while maintaining a hazard
ratio estimate that is more similar to that using the stabilized IPW.
Unfortunately, there were significant overlaps in the confidence interval estimates, which
did not allow a conclusion on the statistical superiority of one method versus the other, especially
without simulation to show the accuracy of the estimates. We would have also preferred larger
resampling of bootstrapping for the precision analysis. However, hardware limitations restricted
the bootstrapping capacity of SAS for such a large dataset and 25 to 200 replications is generally
seem as sufficient for estimating a standard error through bootstrapping. The treatment in our
study, beta-blocker use, did not have a significant treatment effect on adverse cardiac events. We
cannot be sure that a study with a significant treatment effect would not result in clearer
distinction between PS and IPW methods according to theoretical projections. Furthermore, the
limited of time points limited the usefulness of the stabilized IPW method. Future analyses with
multiple time points could be of interest.
Direct implementation of PS as a covariate in the model is a simpler process than the
multiple modeling and calculation required for both truncated and stabilized IPW. However, the
current development of PS limits its use to estimation of direct hazard ratio estimate for treated
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versus untreated, whereas the marginal structural method with IPW allows for the estimation of
effects of other covariates as well, which tells researchers additional information about the
dataset. We would have also liked to include the same comparison with the PS matching method.
But computational limits eliminated that plan. Therefore the comparison between PS and IPW
methods is not necessarily simply for theoretical efficiency and accuracy but also for whether the
study is only interested in the treatment or other covariates as well. Furthermore, current
developments in doubly robust IPW and potential developments in PS that allows for estimation
of total effects could improve the current weakness in each method, respectively, and make for
interesting future comparisons.
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